Valuation: Cencora, Inc.

Market Cap 61.89B 55.31B 50.92B 46.24B 86.55B 5,893B 88.18B 609B 243B 3,088B 232B 227B 9,762B P/E 2026 *
18.1x
P/E 2027 * 20x
Enterprise Value 69.33B 61.96B 57.04B 51.8B 96.95B 6,601B 98.77B 682B 272B 3,459B 260B 255B 10,936B EV / Sales 2026 *
0.21x
EV / Sales 2027 * 0.19x
Free-Float
61.21%
Yield 2026 *
0.72%
Yield 2027 * 0.74%
1 day+1.91%
1 week-2.91%
Current month+10.08%
1 month+8.79%
3 months+3.43%
6 months+5.94%
Current year-2.14%
1 week 320.06
Extreme 320.06
338.07
1 month 295.01
Extreme 295.01
345.46
Current year 244.82
Extreme 244.82
376.92
1 year 244.82
Extreme 244.82
377.54
3 years 182.75
Extreme 182.75
377.54
5 years 113.68
Extreme 113.68
377.54
10 years 68.7
Extreme 68.705
377.54
Manager TitleAgeSince
Chief Executive Officer 59 2024-09-30
Director of Finance/CFO 59 2026-06-28
Chief Tech/Sci/R&D Officer 50 2024-11-03
Director TitleAgeSince
Director/Board Member 75 2013-05-15
Director/Board Member 59 2024-09-30
Chairman 64 2025-09-30
Date Insider Type Main position Quantity % Market Cap. Importance
10/1/26 Other

Director

275 0.0001%
10/1/26 Sell

Controller/Auditor

-986 0.0005%
10/1/26 Other

Director

197 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+1.91%-2.91%-1.52%+76.15% 61.89B
+1.88%+4.04%-17.41%+12.62% 178B
+2.55%+4.75%-17.07%+19.03% 117B
+2.46%+4.39%+4.16%+39.87% 116B
+0.28%+2.53%-43.87%+6.06% 91.03B
-0.32%-0.66%+10.51%+81.65% 55.85B
+1.63%+2.06%+7.67%-21.17% 53.16B
+2.32%+4.07%-9.20%+47.17% 44.35B
+1.94%+5.08%-1.18%-6.94% 33.59B
+1.67%-0.41%+15.46%-10.48% 29.67B
Average +1.53%+0.65%-5.25%+24.40% 77.98B
Weighted average by Cap. +1.44%+1.13%-9.85%+24.79%

Financials

2026 *2027 *
Net sales 337B 301B 277B 252B 471B 32,089B 480B 3,315B 1,321B 16,817B 1,265B 1,238B 53,159B 352B 314B 289B 263B 492B 33,484B 501B 3,459B 1,378B 17,548B 1,320B 1,292B 55,470B
Net income 3.58B 3.2B 2.95B 2.67B 5.01B 341B 5.1B 35.21B 14.03B 179B 13.44B 13.15B 565B 2.84B 2.54B 2.34B 2.13B 3.98B 271B 4.05B 27.98B 11.15B 142B 10.68B 10.45B 449B
Net Debt 7.44B 6.65B 6.12B 5.56B 10.4B 708B 10.6B 73.14B 29.15B 371B 27.91B 27.32B 1,173B 5.95B 5.31B 4.89B 4.44B 8.31B 566B 8.47B 58.48B 23.31B 297B 22.31B 21.84B 938B
Projected Income Statement - Annual - Cencora, Inc.
Logo Cencora, Inc.
Cencora, Inc. specializes in distributing pharmaceutical products. The group supplies generic and name-brand medications, OTC healthcare products, and home care equipment to healthcare providers (hospitals, clinics, pharmacies, physicians, etc.) located in the United States and Canada. The group also offers services to physicians and patients (support and reimbursement assistance services, prescription management services, nursing services, home injection and perfusion services, etc.).
Employees
49,000
Date Price Change Volume
26-10-29 $330.53 +1.91% 1,015,307
26-10-28 $324.35 -0.31% 1,076,740
26-10-27 $325.37 -1.40% 1,123,060
26-10-26 $330.00 -0.30% 993,480
26-10-23 $331.00 -2.21% 1,168,293
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Cencora, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
324.35USD
Average target price
369.08USD
Spread / Average Target
+13.79%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Cencora, Inc.